Skip to main content
Premium Trial:

Request an Annual Quote

Celsee Genesis Single-Cell Analysis Platform

Celsee today launched its Genesis single-cell analysis platform. The tool allows researchers to analyze and interpret cellular behavior and collect cell-based information that was previously undetectable, the firm said. Genesis uses a gentle, gravity-based method to capture and isolate individual cells while maintaining viability and structural integrity. The platform can use both liquid and tissue samples and achieves capture efficiencies of 70 percent or higher. Initial applications include proteogenomics, immune monitoring, and expansion of next-generation sequencing library preparation. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.